CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 26 enrolled
Drug / intervention
Physiogel Daily Defence Protective Day Cream Light +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03136107
NCT03136107N/ACompleted

Determination of the Sun Protection Factor of a Cosmetic Daily Defence Skin Cream

GlaxoSmithKline·interventional·Posted May 2, 2017·Updated Apr 19, 2019

In Brief

A clinical study evaluating Physiogel Daily Defence Protective Day Cream Light and ISO 24444:2010 P3 Standard Sunscreen for Sunscreening Agents. Completed, enrolled 26 participants across 1 site.

Detailed Summary

The purpose of this study is to determine the SPF of the test product according to the International Standards Organization (ISO) 24444:2010 methodology (In vivo determination of the SPF).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedMay 2, 2017
Enrollment StartMay 30, 2017
Primary CompletionJun 30, 2017
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 9.2 years ago

Interventions

Physiogel Daily Defence Protective Day Cream Lightother

Investigator controlled, topical application to the epidermis at a dose of 2 milligrams per square centimeter (mg/cm2). Single application.

ISO 24444:2010 P3 Standard Sunscreenother

Investigator controlled, topical application to the epidermis at a dose of 2 mg/cm2. Single application.